News
ADVM
--
0.00%
--
Sonic Fund II, L.P. Buys Maxar Technologies Inc, Community Health Systems Inc, Tupperware ...
GuruFocus News · 08/18 18:38
The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17)
Benzinga · 08/18 11:37
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16)
Benzinga · 08/17 12:28
Frazier Management Llc Buys Iovance Biotherapeutics Inc, Chinook Therapeutics Inc, Autolus ...
GuruFocus News · 08/13 18:38
BRIEF-Adverum Biotechnologies Says Christopher Derespino, Acting CFO Advised Adverum That He Was Resigning As An Officer
reuters.com · 08/11 10:30
MVST, MDRX, ETON and GDS among after hours movers
Gainers: JD +4.7%. MVST +3.9%. MDRX +3.7%. MCFE +2.8%. ADVM +2.8%. Losers: ETON -12.9%. GDS -6.7%. PRTK -5.1%. PDD -3.0%. NAUT -1.7%.
Seekingalpha · 08/06 21:42
Why Adverum Biotechnologies (ADVM) Might Surprise This Earnings Season
Zacks.com · 08/06 14:19
BRIEF-Adverum Reports Second Quarter 2021 Results
reuters.com · 08/05 21:50
Adverum Biotechnologies EPS misses by $0.07
Adverum Biotechnologies (NASDAQ:ADVM): Q2 GAAP EPS of -$0.45 misses by $0.07. Cash, cash equivalents and short-term investments of $363.8M Press Release
Seekingalpha · 08/05 21:25
What's in Store for Harrow Health (HROW) in Q2 Earnings?
Zacks.com · 08/05 14:57
BioNTech (BNTX) to Report Q2 Earnings: What's in the Cards?
Zacks.com · 08/03 14:09
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2)
Benzinga · 08/03 11:55
Stocks That Hit 52-Week Lows On Monday
    Monday morning, 34 companies reached new 52-week lows.
Benzinga · 08/02 14:01
Bionano (BNGO) to Report Q2 Earnings: What's in the Cards?
Zacks.com · 07/29 16:51
75 Biggest Movers From Friday
Gainers The New Home Company Inc. (NYSE: NWHM) jumped 82.9% to settle at $8.89 on Friday after the company agreed to be acquired by funds managed by affiliates of Apollo Global Management for $9 per share in all-cash transaction.
Benzinga · 07/26 09:14
Hot Stocks: RHI drives recruiters MAN, KFRC; low-cost retailers hit highs; UP goes down; VNE, NWHM get bought
champc/iStock via Getty Images While earnings dominated Wall Street conversation on Friday, a couple of other simmering themes exerted influence as well. For instance, the tight labor market helped drive
Seekingalpha · 07/23 21:26
Where Adverum Biotechnologies Stands With Analysts
Analysts have provided the following ratings for Adverum Biotechnologies (NASDAQ:ADVM) within the last quarter: Last 30 Days 1 Month Ago
Benzinga · 07/23 18:58
Xenetic Biosciences, Medigus leads healthcare gainers; ImmunoPrecise Antibodies, Adverum Biotechnologies among major losers
Gainers: Xenetic Biosciences XBIO +126%, Medigus MDGS+35%, Acorda Therapeutics ACOR +30%, NRx Pharmaceuticals NRXP +14%, Apollo Medical (AMEH) +13%.Losers: ImmunoPrecise Antibodies (IPA) -36%, Adverum Biotechnologies ADVM -23%, Chembio Diagnostics (CEMI) -...
Seekingalpha · 07/23 15:05
Adverum plunges as analysts turn bearish citing setback for diabetic macular edema drug
Shidlovski/iStock via Getty Images Trading ~18.3% lower in the early trading, Adverum Biotechnologies (ADVM) has extended the post-market losses after the company announced the discontinuation of its plans to develop ADVM-022 for
Seekingalpha · 07/23 12:45
DiDi Global, KE Holdings, TAL Education among premarket losers' pack
New Oriental Education & Technology EDU -63% on report China considering tutoring companies become non profits.Gaotu Techedu GOTU -59% on report China considering tutoring companies become non profits.TAL Education TAL -53% on report China considering tuto...
Seekingalpha · 07/23 12:26
Webull provides a variety of real-time ADVM stock news. You can receive the latest news about Adverum through multiple platforms. This information may help you make smarter investment decisions.
About ADVM
Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company targeting unmet medical needs for serious ocular and rare diseases. The Company is evaluating its gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of its lead indication, wet age-related macular degeneration. It has collaboration agreement with Regeneron Pharmaceuticals, Inc. to research, develop, and commercialize gene therapy products (AVA-311) for ophthalmic diseases. The Company develops gene therapy product candidates designed to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its capabilities include clinical development, vector discovery, and in-house manufacturing, specifically in process development, assay development and current Good Manufacturing Practices (cGMP) quality control.